6-amino-5-cyano-pyrimidine-4-ones used for improving perception, power of concentration, learning efficiency, and/ or memory power

Details for Australian Patent Application No. 2004313696 (hide)

Owner Boehringer Ingelheim International GmbH

Inventors Hendrix, Martin; Tersteegen, Adrian; Heckroth, Heike; Barfacker, Lars; Karthaus, Dagmar

Agent Davies Collison Cave

Pub. Number AU-B-2004313696

PCT Pub. Number WO2005/068436

Priority 102004001873.1 14.01.04 DE

Filing date 31 December 2004

Wipo publication date 28 July 2005

Acceptance publication date 18 August 2011

International Classifications

C07D 239/46 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

C07D 401/04 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 401/06 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 403/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 405/06 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 405/12 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 405/14 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 409/06 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

C07D 409/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

C07D 491/10 (2006.01) Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or

Event Publications

31 August 2006 PCT application entered the National Phase

  PCT publication WO2005/068436 Priority application(s): WO2005/068436

19 April 2007 Assignment before Grant

  Bayer Healthcare AG The application has been assigned to Boehringer Ingelheim International GmbH

18 August 2011 Application Accepted

  Published as AU-B-2004313696

22 December 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under reg. 22.2I(2). This application has been accepted or advertised accepted. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004313698-Process for the purification of bacterially expressed proteins

2004313695-Tricyclic benzazepine derivatives as squalene synthase inhibitors used for the treatment of cardiovascular diseases